TransCelerate Launches Three New Initiatives


Applied Clinical Trials

TransCelerate BioPharma has launched three new initiatives. The Common Clinical Serious Adverse Events (SAE) Fields Initiative, The Modernization of Data Analytics for Clinical Development Initiative aims, and has expanded its Interpretation of Guidances and Regulations Initiative.

For more on the new initiatives, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.